Log in to save to my catalogue

Population pharmacokinetics of ospemifene and safety evaluation of pharmacokinetic alterations cause...

Population pharmacokinetics of ospemifene and safety evaluation of pharmacokinetic alterations cause...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1899185901

Population pharmacokinetics of ospemifene and safety evaluation of pharmacokinetic alterations caused by intrinsic and extrinsic factors

About this item

Full title

Population pharmacokinetics of ospemifene and safety evaluation of pharmacokinetic alterations caused by intrinsic and extrinsic factors

Publisher

Germany: Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG

Journal title

International journal of clinical pharmacology and therapeutics, 2017-04, Vol.55 (4), p.339-347

Language

English

Formats

Publication information

Publisher

Germany: Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG

More information

Scope and Contents

Contents

To develop a population pharmacokinetic (PPK) model to assess factors influencing ospemifene pharmacokinetics and to assess safety for pharmacokinetic alteration observed in drug development.
A PPK model was constructed using pooled ospemifene concentrations. Covariates considered before start of the analysis were: age, race, body weight, BMI, a...

Alternative Titles

Full title

Population pharmacokinetics of ospemifene and safety evaluation of pharmacokinetic alterations caused by intrinsic and extrinsic factors

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1899185901

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1899185901

Other Identifiers

ISSN

0946-1965

DOI

10.5414/CP202821

How to access this item